Cytomegalovirus Replication Kinetics in Solid Organ Transplant Recipients Managed by Preemptive Therapy
Open Access
- 17 May 2012
- journal article
- Published by Elsevier BV in American Journal of Transplantation
- Vol. 12 (9), 2457-2464
- https://doi.org/10.1111/j.1600-6143.2012.04087.x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Cytomegalovirus quantification: Where to next in optimising patient management?Journal of Clinical Virology, 2011
- Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trialThe Lancet, 2011
- The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk Kidney Transplant RecipientsAmerican Journal of Transplantation, 2010
- Intragraft Cytomegalovirus Infection: A Randomized Trial of Valacyclovir Prophylaxis versus Pre-Emptive Therapy in Renal Transplant RecipientsAntiviral Therapy, 2010
- Prophylactic Versus Preemptive Oral Valganciclovir for the Management of Cytomegalovirus Infection in Adult Renal Transplant RecipientsAmerican Journal of Transplantation, 2006
- Modelling cytomegalovirus replication patterns in the human host: factors important for pathogenesisProceedings Of The Royal Society B-Biological Sciences, 2006
- Preemptive oral ganciclovir therapy versus prophylaxis to prevent symptomatic cytomegalovirus infection after kidney transplantationTransplantation Proceedings, 2001
- Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplantsThe Lancet, 2000
- Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantationThe Lancet, 2000
- Infection in Organ-Transplant RecipientsNew England Journal of Medicine, 1998